Studi in-silico: Screening Virtual Senyawa Triterpenoid pada Canophyllum inophyllum Sebagai Kandidat Inhibitor SARS-CoV-2
DOI:
https://doi.org/10.25077/jfu.14.5.459-465.2025Keywords:
SARS-CoV-2, Main protease, Triterpenoid, Molecular DockingAbstract
This study aims to identify the potential of triterpenoid compounds from tamanu (Canophyllum inophyllum) as SARS-CoV-2 inhibitors through an in-silico approach using molecular docking. Ten triterpenoid compounds were selected and their binding affinity to the main protease (Mpro) of SARS-CoV-2 (PDB ID: 6W63) was tested. The results showed that four triterpenoid compounds, including oleanolic acid (-8.2 kcal/mol), friedelin (-8.2 kcal/mol), inophynone (-8.1 kcal/mol), and epifriedelanol (-8.2 kcal/mol) had lower binding affinity compared to the natural ligand (X77 -8.0 kcal/mol) and its reference ligand (paxlovid -7.7 kcal/mol), indicating a stronger interaction with the active site of the protein. Among the four candidates, only oleanolic acid forms hydrogen bonds with amino acid residues in the active site of the protein, which strengthens its potential role as a SARS-CoV-2 inhibitor. This finding suggests that these compounds, especially oleanolic acid, have the potential to be further developed as natural product-based Covid-19 therapies. This study provides an initial contribution to the exploration of natural products as a source of active compounds for the development of Covid-19 therapies through an in-silico approach.
References
Bege, M., & Borbás, A. (2024). The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19. Pharmaceutics, 16(2), 217. https://doi.org/10.3390/pharmaceutics16020217
Çubuk, H., & Özbil, M. (2021). Comparison of clinically approved molecules on SARS-CoV-2 drug target proteins: A molecular docking study. Turkish Journal of Chemistry, 45(1), 35–41. https://doi.org/10.3906/KIM-2008-35
Meiyanto, E. (2012). Docking Kurkumin Dan Senyawa Analognya Pada Reseptor Progesteron: Studi Interaksinya Sebagai Selective Progesterone Receptor Modulators (SPRMs). Pharmacon: Jurnal Farmasi Indonesia, 13(2), 55–60. https://doi.org/10.23917/pharmacon.v13i2.10
Perdana, A. T., & Permana, A. A. (2021). Molecular Docking Senyawa Potensial Anticovid-19 Secara In Silico. JIKA (Jurnal Informatika), 5(2), 159. https://doi.org/10.31000/jika.v5i2.4516
Rena, S. R., Nurhidayah, N., & Rustan, R. (2022). Analisis Molecular Docking Senyawa Garcinia Mangostana L Sebagai Kandidat Anti SARS-CoV-2. Jurnal Fisika Unand, 11(1), 82–88. https://doi.org/10.25077/jfu.11.1.82-88.2022
Ruswanto, R., Mardianingrum, R., & Yanuar, A. (2022). Computational Studies of Thiourea Derivatives as Anticancer Candidates through Inhibition of Sirtuin-1 (SIRT1). Jurnal Kimia Sains Dan Aplikasi, 25(3), 87–96. https://doi.org/10.14710/jksa.25.3.87-96
Shitrit, A., Zaidman, D., Kalid, O., Bloch, I., Doron, D., Yarnizky, T., Buch, I., Segev, I., Ben-Zeev, E., Segev, E., & Kobiler, O. (2020). Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Scientific Reports, 10(1), 20808. https://doi.org/10.1038/s41598-020-77794-5
Sumaryada, T., Pramudita, C. A. (2020). Molecular Docking Evaluation of Some Indonesian’s Popular Herbals for a Possible COVID-19 Treatment. Biointerface Research in Applied Chemistry, 11(3), 9827–9835. https://doi.org/10.33263/BRIAC113.98279835
Suryadewi, K. D., & Pratama, I. P. A. A. C. (2022). Uji Senyawa Mirisetin Sebagai Antiinflamasi Melalui Pendekatan In Silico Molecular Docking. Acta Holistica Pharmaciana, 4(1), 39–47. https://doi.org/10.62857/ahp.v4i1.64
Wandi, I. A., Samudra, J. A., Khoirul Umam, R. N., Asih, R. S., Nafiah, M., Nur Jannah, S., & Ferniah, R. S. (2022). Eksplorasi Senyawa Antiretroviral dari Biji Tanaman Calophyllum inophyllum L. sebagai Alternatif Obat AIDS secara In Silico. Bioma : Berkala Ilmiah Biologi, 24(1), 24–29. https://doi.org/10.14710/bioma.24.1.24-29
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Suci Ramda Rena, Afdhal Muttaqin, Dian Fitriyani

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.













